Equity Research firms currently have a positive stance on shares of Ocera Therapeutics, Inc. (NASDAQ:OCRX). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.50. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $9.75 on a short term basis.
At the time of writing, the stock was trading at $2.85. This represents a change from the opening price of 0.00%. In terms of performance, year to date, the stock is -8.65%. The monthly stock performance comes in at 21.28%. For the quarter, shares are performing at 9.20%. Weekly performance analysis shows the equity at 9.20%.
In taking a look at technical levels, shares are trading 14.77% away from the 50 day simple moving average and 6.20% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -37.64% away from it’s 52- week high and 62.02% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Ocera Therapeutics, Inc.’s RSI stands at 61.04. In looking at volatility levels, the shares saw weekly volatility of 11.81% and 11.77% over the past month.